Wellnex Life (ASX:WNX): Trading update YTD FY25

Wellnex Life Limited (Wellnex, WNX or Company) (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently published a key ASX announcement. 


WNX-Wellnex-Life-BPC--Investor-Relations-Case-Study

 

Wellnex Life Limited (ASX) ("Wellnex Life" or the "Company"), is pleased to share the trading update YTD FY25. After a slow start for FY25, Wellnex is now seeing continued growth with sales for the first 5 months of FY25 ($8.92 million) up 66% compared to the same period for FY24 ($5.36 million).

 

Announcement Highlights

  1. Total sales for Jul-Nov FY25 increased to $8.92 million, up 66% compared to the same period for FY24 ($5.36 million).
  2. Strong brand sales in the period, increasing 137% in FY25 ($6.47 million) compared to the same period in FY24 ($2.73 million).
  3. Momentum increasing, with 321% increase of sales recorded for November 2024 ($3.16 million).

A huge congratulations to George Karafotias, Zack Bozinovski, the board and the team at WNX for reaching this milestone.

Read the full Wellnex Life Company Update here.

 


To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.